U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07171619) titled 'Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat' on Aug. 07.
Brief Summary: This study will evaluate the effects of the H2 blocker famotidine or the PPI rabeprazole on the PK of nirogacestat in healthy male participants
Study Start Date: Sept. 09
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Nirogacestat
oral dose of 150 mg nirogacestat
DRUG: Nirogacestat and Famotidine
oral dose of 150 mg nirogacestat & oral dose of 40 mg famotidine
DRUG: Nirogacestat and Rabeprazole
oral dose of 150 mg nirogacestat and oral dose of 20 mg rabeprazole
Recruitment Status: RECRUITING
Sponso...